Adele Busico

2.5k total citations
48 papers, 779 citations indexed

About

Adele Busico is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Adele Busico has authored 48 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 22 papers in Pulmonary and Respiratory Medicine and 19 papers in Cancer Research. Recurrent topics in Adele Busico's work include Cancer Genomics and Diagnostics (18 papers), Lung Cancer Treatments and Mutations (16 papers) and Colorectal Cancer Treatments and Studies (9 papers). Adele Busico is often cited by papers focused on Cancer Genomics and Diagnostics (18 papers), Lung Cancer Treatments and Mutations (16 papers) and Colorectal Cancer Treatments and Studies (9 papers). Adele Busico collaborates with scholars based in Italy, United States and Georgia. Adele Busico's co-authors include Federica Perrone, Filippo de Braud, Elena Tamborini, Filippo Pietrantonio, Maria Di Bartolomeo, Annunziata Gloghini, Giovanni Centonze, Ugo Pastorino, Luigi Mariani and Marina Chiara Garassino and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Adele Busico

45 papers receiving 775 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adele Busico Italy	15	351	231	225	206	159	48	779
Wai Chin Foo United States	15	389 1.1×	297 1.3×	152 0.7×	287 1.4×	82 0.5×	51	820
Soo Kee Min South Korea	16	309 0.9×	181 0.8×	219 1.0×	128 0.6×	87 0.5×	58	744
Rossella De Cecio Italy	17	393 1.1×	139 0.6×	171 0.8×	248 1.2×	109 0.7×	47	706
T. Geldart United Kingdom	15	293 0.8×	211 0.9×	202 0.9×	178 0.9×	67 0.4×	40	642
K. Tsuta Japan	14	314 0.9×	161 0.7×	258 1.1×	382 1.9×	97 0.6×	23	779
Kiyong Na South Korea	18	157 0.4×	199 0.9×	175 0.8×	222 1.1×	83 0.5×	66	835
María Gómez Galdón Belgium	14	487 1.4×	225 1.0×	122 0.5×	156 0.8×	67 0.4×	31	732
Kristýna Němejcová Czechia	18	221 0.6×	242 1.0×	224 1.0×	130 0.6×	144 0.9×	94	865
Guowen Wang China	18	475 1.4×	200 0.9×	183 0.8×	554 2.7×	41 0.3×	29	873
Martin J. Magers United States	15	172 0.5×	493 2.1×	229 1.0×	292 1.4×	52 0.3×	26	948

Countries citing papers authored by Adele Busico

Since Specialization

Citations

This map shows the geographic impact of Adele Busico's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adele Busico with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adele Busico more than expected).

Fields of papers citing papers by Adele Busico

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adele Busico. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adele Busico. The network helps show where Adele Busico may publish in the future.

Co-authorship network of co-authors of Adele Busico

This figure shows the co-authorship network connecting the top 25 collaborators of Adele Busico. A scholar is included among the top collaborators of Adele Busico based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adele Busico. Adele Busico is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Appierto, Valentina, Elena Tamborini, Paola Tiberio, et al.. (2025). Circulating tumor DNA to anticipate loco-regional recurrence in early-stage breast cancer: a proof-of-concept study. Frontiers in Oncology. 15. 1621322–1621322.

Bozzi, Fabio, Elena Conca, Marco Silvestri, et al.. (2025). Detecting gene copy number alterations by Oncomine Comprehensive genomic profiling in a comparative study on FFPE tumor samples. Scientific Reports. 15(1). 4314–4314. 1 indexed citations

Vallacchi, Viviana, Elisabetta Vergani, Mara Cossa, et al.. (2024). Multistep tumor genetic evolution and changes in immunogenicity trigger immune-mediated disease eradication in stage IV melanoma: lessons from a single case. Journal for ImmunoTherapy of Cancer. 12(1). e007612–e007612. 1 indexed citations

Minna, Emanuela, Biagio Paolini, Sonia Pagliardini, et al.. (2023). Genomic and transcriptomic analyses of thyroid cancers identify DICER1 somatic mutations in adult follicular-patterned RAS-like tumors. Frontiers in Endocrinology. 14. 1267499–1267499. 6 indexed citations

Kusamura, Shigeki, Adele Busico, Elena Conca, et al.. (2023). A2AR Expression and Immunosuppressive Environment Independent of KRAS and GNAS Mutations in Pseudomyxoma Peritonei. Biomedicines. 11(7). 2049–2049. 5 indexed citations

Cosimo, Serena Di, Cinzia De Marco, Marco Silvestri, et al.. (2023). Can we define breast cancer HER2 status by liquid biopsy?. International review of cell and molecular biology. 381. 23–56. 6 indexed citations

Vingiani, Andrea, Daniele Lorenzini, Elena Conca, et al.. (2023). Pan-TRK immunohistochemistry as screening tool for NTRK fusions: A diagnostic workflow for the identification of positive patients in clinical practice. Cancer Biomarkers. 38(3). 301–309. 4 indexed citations

Azzollini, Jacopo, Luca Agnelli, Elena Conca, et al.. (2023). Prevalence of BRCA homopolymeric indels in an ION Torrent-based tumour-to-germline testing workflow in high-grade ovarian carcinoma. Scientific Reports. 13(1). 7781–7781. 2 indexed citations

Capone, Iolanda, Fabio Bozzi, Gian Paolo Dagrada, et al.. (2022). Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples. SHILAP Revista de lepidopterología. 3(5). 582–597. 3 indexed citations

10.

Borzi, Cristina, Monica Ganzinelli, Elisa Caiola, et al.. (2021). LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress–Based Treatments. Journal of Thoracic Oncology. 16(8). 1298–1311. 16 indexed citations

11.

Milione, Massimo, Mattia Boeri, Anna Cantarutti, et al.. (2020). Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture Analysis. Cancers. 12(7). 1828–1828. 1 indexed citations

12.

Minna, Emanuela, Silvia Brich, Katia Todoerti, et al.. (2020). Cancer Associated Fibroblasts and Senescent Thyroid Cells in the Invasive Front of Thyroid Carcinoma. Cancers. 12(1). 112–112. 40 indexed citations

13.

Vernieri, Claudio, Monica Ganzinelli, Eliana Rulli, et al.. (2020). LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial. ESMO Open. 5(3). e000748–e000748. 5 indexed citations

14.

Moro, Massimo, Elisa Caiola, Monica Ganzinelli, et al.. (2018). Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC. Journal of Thoracic Oncology. 13(11). 1692–1704. 80 indexed citations

15.

Necchi, Andrea, Salvatore Lo Vullo, Patrizia Giannatempo, et al.. (2017). Pazopanib in advanced germ cell tumors after chemotherapy failure: results of the open-label, single-arm, phase 2 Pazotest trial. Annals of Oncology. 28(6). 1346–1351. 31 indexed citations

16.

Necchi, Andrea, Salvatore Lo Vullo, Daniele Raggi, et al.. (2017). Neoadjuvant sorafenib, gemcitabine, and cisplatin administration preceding cystectomy in patients with muscle-invasive urothelial bladder carcinoma: An open-label, single-arm, single-center, phase 2 study. Urologic Oncology Seminars and Original Investigations. 36(1). 8.e1–8.e8. 11 indexed citations

17.

Pietrantonio, Filippo, Daniele Oddo, Annunziata Gloghini, et al.. (2016). MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF -Mutated Colorectal Cancer. Cancer Discovery. 6(9). 963–971. 78 indexed citations

18.

Pelosi, Giuseppe, Federica Perrone, Elena Tamborini, et al.. (2016). Doing more with less: fluorescence in situ hybridization and gene sequencing assays can be reliably performed on archival stained tumor tissue sections. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 468(4). 451–461. 1 indexed citations

19.

Pelosi, Giuseppe, Alessandra Fabbri, Elena Tamborini, et al.. (2015). Challenging Lung Carcinoma with Coexistent ΔNp63/p40 and Thyroid Transcription Factor-1 Labeling Within the Same Individual Tumor Cells. Journal of Thoracic Oncology. 10(10). 1500–1502. 18 indexed citations

20.

Pietrantonio, Filippo, Federica Perrone, Filippo de Braud, et al.. (2013). Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation. Annals of Oncology. 25(2). 404–408. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact